Press Releases

May 21, 2015 -- Glucose Health, Inc. Announces New Product for OTC Diabetic Supplies Category

BENTONVILLE, AR – Glucose Health, Inc. (OTC: GLUC) today announced completion of the first production run of Glucose Health™ Natural Blood Sugar Maintenance – an innovative new product targeting the Type-2 Diabetes consumer market segment. 

Glucose Health™ is of particular interest to 86 million Americans – the latest Centers for Disease Control and Prevention (CDC) estimate of persons who will develop Type-2 Diabetes in their lifetime.1 Glucose Health™ is a superior product to the established national brands often recommended by pharmacists, doctors and dieticians...

Read more


Glucose Health Relocates HQ From Florida to Bentonville Plaza

by Paul Gatling
NW Business Journal

Glucose Health Inc., a publicly traded company previously headquartered in West Palm Beach, Florida, has relocated its corporate headquarters to Northwest Arkansas.

GHI, which has seven employees, will maintain its corporate headquarters at Bentonville Plaza.

GHI manufactures its flagship line of non-prescription Glucose Health products in the beverage category that helps Type...

Read more


Glucose Health to relocate corporate office to Bentonville

Submitted by The City Wire Staff on Tue, 03/03/2015 - 10:18am

Nutraceutical maker Glucose Health announced plans to relocate its small corporate office from West Palm Beach, Fla., to Bentonville near its manufacturing, sales and marketing operations. The new address will be 609 S.W. Eighth St., Suite 600, Bentonville, AR.

“We manufacture our products in Northwest Arkansas and all of our shipping and fulfillment


Read more

February 24, 2015 -- Glucose Health, Inc. Announces FDA Facility Registration

WEST PALM BEACH, FL – Glucose Health, Inc. (OTC: GLUC) today announced its has completed Food & Drug Administration (FDA) facility registration, a compliance procedure for manufacturers of dietary and nutritional supplements. FDA facility registration is the final step in a series regulatory compliance procedures implemented by the Company, beginning in fourth quarter of 2014.

Glucose Health, Inc. CEO Murray Fleming commented:

“Compliance with FDA regulations is an essential prerequisite to Glucose Health, Inc. products being vetted and approved for sale on the shelves...

Read more